These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2543940

  • 21. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
    You M, Bose HR.
    Methods; 1998 Dec; 16(4):373-85. PubMed ID: 10049645
    [Abstract] [Full Text] [Related]

  • 22. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T.
    Gilmore TD, Temin HM.
    Cell; 1986 Mar 14; 44(5):791-800. PubMed ID: 3004745
    [Abstract] [Full Text] [Related]

  • 23. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D, Rizzo CA, Dorfman K, Bravo R.
    EMBO J; 1996 Jul 15; 15(14):3640-50. PubMed ID: 8670867
    [Abstract] [Full Text] [Related]

  • 24. Structure of a mammalian c-rel protein deduced from the nucleotide sequence of murine cDNA clones.
    Grumont RJ, Gerondakis S.
    Oncogene Res; 1989 Jul 15; 4(1):1-8. PubMed ID: 2654811
    [Abstract] [Full Text] [Related]

  • 25. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts.
    Sif S, Capobianco AJ, Gilmore TD.
    Oncogene; 1993 Sep 15; 8(9):2501-9. PubMed ID: 8361761
    [Abstract] [Full Text] [Related]

  • 26. v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells.
    Gilmore TD, Temin HM.
    J Virol; 1988 Mar 15; 62(3):703-14. PubMed ID: 2828665
    [Abstract] [Full Text] [Related]

  • 27. The viral and cellular Rel oncoproteins induce the differentiation of P19 embryonal carcinoma cells.
    Inuzuka M, Ishikawa H, Kumar S, Gélinas C, Ito Y.
    Oncogene; 1994 Jan 15; 9(1):133-40. PubMed ID: 8302572
    [Abstract] [Full Text] [Related]

  • 28. Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells.
    Sun SC, Maggirwar SB, Harhaj EW, Uhlik M.
    Oncogene; 1999 Feb 18; 18(7):1401-9. PubMed ID: 10050877
    [Abstract] [Full Text] [Related]

  • 29. v-rel and c-rel induce a membrane protein, p75, on avian hematopoietic cells.
    Zhang G, Humphries EH.
    Oncogene; 1996 Mar 07; 12(5):1153-7. PubMed ID: 8649808
    [Abstract] [Full Text] [Related]

  • 30. Structure and expression of c-rel, the cellular homolog to the oncogene of reticuloendotheliosis virus strain T.
    Chen IS, Wilhelmsen KC, Temin HM.
    J Virol; 1983 Jan 07; 45(1):104-13. PubMed ID: 6296425
    [Abstract] [Full Text] [Related]

  • 31. Expression of the oncogene of avian reticuloendotheliosis virus in Escherichia coli and identification of the transforming protein in reticuloendotheliosis virus T-transformed cells.
    Herzog NK, Bose HR.
    Proc Natl Acad Sci U S A; 1986 Feb 07; 83(3):812-6. PubMed ID: 3003751
    [Abstract] [Full Text] [Related]

  • 32. Overproduction of NFKB2 (lyt-10) and c-Rel: a mechanism for HTLV-I Tax-mediated trans-activation via the NF-kappa B signalling pathway.
    Lanoix J, Lacoste J, Pepin N, Rice N, Hiscott J.
    Oncogene; 1994 Mar 07; 9(3):841-52. PubMed ID: 8108127
    [Abstract] [Full Text] [Related]

  • 33. A recombinant murine retrovirus expressing v-rel is cytopathic.
    Schwartz RC, Witte ON.
    Virology; 1988 Jul 07; 165(1):182-90. PubMed ID: 2838956
    [Abstract] [Full Text] [Related]

  • 34. Transactivation of gene expression by nuclear and cytoplasmic rel proteins.
    Hannink M, Temin HM.
    Mol Cell Biol; 1989 Oct 07; 9(10):4323-36. PubMed ID: 2555689
    [Abstract] [Full Text] [Related]

  • 35. Association of v-myc protein with chromatin.
    Klempnauer KH.
    Oncogene; 1989 Jan 07; 4(1):115-8. PubMed ID: 2644610
    [Abstract] [Full Text] [Related]

  • 36. Localization of the v-rel protein in reticuloendotheliosis virus strain T-transformed lymphoid cells.
    Simek SL, Stephens RM, Rice NR.
    J Virol; 1986 Jul 07; 59(1):120-6. PubMed ID: 3012110
    [Abstract] [Full Text] [Related]

  • 37. The v-rel oncogene product is complexed to a 40-kDa phosphoprotein in transformed lymphoid cells.
    Tung HY, Bargmann WJ, Lim MY, Bose HR.
    Proc Natl Acad Sci U S A; 1988 Apr 07; 85(8):2479-83. PubMed ID: 3357877
    [Abstract] [Full Text] [Related]

  • 38. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-kappa B p65 and c-Rel proteins bound to the NF-kappa B binding site and activates transcription.
    Suzuki T, Hirai H, Yoshida M.
    Oncogene; 1994 Nov 07; 9(11):3099-105. PubMed ID: 7936632
    [Abstract] [Full Text] [Related]

  • 39. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
    Fan Y, Gélinas C.
    Oncogene; 2007 Jun 07; 26(27):4038-43. PubMed ID: 17173064
    [Abstract] [Full Text] [Related]

  • 40. Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein.
    Epinat JC, Kazandjian D, Harkness DD, Petros S, Dave J, White DW, Gilmore TD.
    Oncogene; 2000 Feb 03; 19(5):599-607. PubMed ID: 10698504
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.